Core Laboratories NV
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and … Read more
Core Laboratories NV (CLB) - Total Liabilities
Latest total liabilities as of December 2025: $317.19 Million USD
Based on the latest financial reports, Core Laboratories NV (CLB) has total liabilities worth $317.19 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Core Laboratories NV - Total Liabilities Trend (1995–2025)
This chart illustrates how Core Laboratories NV's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Core Laboratories NV Competitors by Total Liabilities
The table below lists competitors of Core Laboratories NV ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chambal Fertilizers & Chemicals Limited
NSE:CHAMBLFERT
|
India | ₹40.31 Billion |
|
Northwest Healthcare Properties REIT
PINK:NWHUF
|
USA | $3.40 Billion |
|
Lin BioScience Inc.
TWO:6696
|
Taiwan | NT$139.81 Million |
|
Maanshan Iron & Steel Company Limited
PINK:MAANF
|
USA | $49.80 Billion |
|
Jinzi Ham Co Ltd
SHE:002515
|
China | CN¥57.75 Million |
|
Nagarro SE
PINK:NGRRF
|
USA | $577.55 Million |
|
Jiangxi Ganyue Expressway Co Ltd
SHG:600269
|
China | CN¥16.49 Billion |
|
ZWSOFT Guangzhou Co Ltd
SHG:688083
|
China | CN¥561.65 Million |
Liability Composition Analysis (1995–2025)
This chart breaks down Core Laboratories NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.21 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Core Laboratories NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Core Laboratories NV (1995–2025)
The table below shows the annual total liabilities of Core Laboratories NV from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $317.19 Million | -4.65% |
| 2024-12-31 | $332.67 Million | -6.71% |
| 2023-12-31 | $356.59 Million | -8.43% |
| 2022-12-31 | $389.40 Million | -7.25% |
| 2021-12-31 | $419.85 Million | -14.84% |
| 2020-12-31 | $493.01 Million | -16.80% |
| 2019-12-31 | $592.53 Million | +21.44% |
| 2018-12-31 | $487.93 Million | +11.89% |
| 2017-12-31 | $436.08 Million | +4.39% |
| 2016-12-31 | $417.75 Million | -35.63% |
| 2015-12-31 | $648.96 Million | +11.57% |
| 2014-12-31 | $581.66 Million | +18.31% |
| 2013-12-31 | $491.62 Million | +9.59% |
| 2012-12-31 | $448.60 Million | +5.93% |
| 2011-12-31 | $423.48 Million | +23.21% |
| 2010-12-31 | $343.70 Million | -8.69% |
| 2009-12-31 | $376.41 Million | -0.25% |
| 2008-12-31 | $377.34 Million | -14.47% |
| 2007-12-31 | $441.16 Million | +3.09% |
| 2006-12-31 | $427.93 Million | +138.70% |
| 2005-12-31 | $179.28 Million | -9.19% |
| 2004-12-31 | $197.43 Million | -1.24% |
| 2003-12-31 | $199.92 Million | +22.90% |
| 2002-12-31 | $162.66 Million | -0.26% |
| 2001-12-31 | $163.08 Million | +3.97% |
| 2000-12-31 | $156.86 Million | +3.95% |
| 1999-12-31 | $150.90 Million | +0.27% |
| 1998-12-31 | $150.50 Million | +22.66% |
| 1997-12-31 | $122.70 Million | +282.24% |
| 1996-12-31 | $32.10 Million | +14.23% |
| 1995-12-31 | $28.10 Million | -- |